Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Oslo Bors  >  Lifecare AS    LIFE-ME   NO0010591191

LIFECARE AS

(LIFE-ME)
  Report
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Lifecare AS : (LIFE-ME) - Increase of share capital following exercise of share option program and share sale by close associate to primary insider

share with twitter share with LinkedIn share with facebook
09/25/2020 | 12:08pm EDT
Reference is made to the stock exchange announcement by Lifecare AS (the
Company) August 6th, 2020 regarding the exercise of 325.826 share options with a
strike price of NOK 0,40 per share option, by Islay Venture GmbH - a company
controlled by the Company CSO Prof. Dr. Dr. med Andreas Pfützner. 

Based on authorization granted by the Company extraordinary general meeting July
30th, 2020, the Board of Directors of the Company has resolved to issue 325.826
new shares for an aggregated subscription price of NOK 130.330,40, corresponding
to a strike price of NOK 0,40 per share. Following the issuance of the new
shares, the Company will have 81.278.170 shares outstanding, each with a nominal
value of NOK 0,40. Total share capital of the Company will be NOK 32.511.268. 

Islay Venture GmbH has sold 50.000 shares at an average price of NOK 5,40,
whereafter Islay Venture GmbH hold a total of 853.951 shares in Lifecare AS

For more information, please contact:
Joacim Holter
CEO, Lifecare
joacim.holter@lifecare.no
+47 40 05 90 40

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange


share with twitter share with LinkedIn share with facebook
All news about LIFECARE AS
10/05LIFECARE : participating in research project awarded EUR 3,9 million from the EU..
AQ
09/25LIFECARE AS : (LIFE-ME) - Increase of share capital following exercise of share ..
AQ
09/15LIFECARE : Lifecares Joint Venture partner Digital Diagnostics AG select WISeKey..
PU
More news
Financials
Sales 2019 - - -
Net income 2019 -6,55 M -0,71 M -0,71 M
Net cash 2019 14,6 M 1,59 M 1,59 M
P/E ratio 2019 -40,7x
Yield 2019 -
Capitalization 536 M 58,3 M 58,3 M
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees -
Free-Float 100%
Chart LIFECARE AS
Duration : Period :
Lifecare AS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LIFECARE AS
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Managers
NameTitle
Joacim Holter Chief Executive Officer & Director
Christian Hysing-Dahl Chairman
Rune Frisvold Managing Director & Chief Operating Officer
Andreas Pfützner Chief Scientific Officer
Konstantin Kloppstech Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
LIFECARE AS103.03%49
LONZA GROUP AG64.78%47 655
SEAGEN INC.73.31%34 455
IQVIA HOLDINGS INC.12.29%33 260
CELLTRION, INC.34.81%28 816
MODERNA, INC.264.57%28 138